Outcome MeasureOther

SF-MPQ

Short Form McGill Pain Questionnaire

2 Papers in Blossom

Outcome Data Across Studies

Reported results for SF-MPQ across 1 study with quantitative data.

Outcome data across 5 study arm–timepoint observations
SD
Pilot study of psilocybin in patients with post-treatment lyme disease
2026Secondary
Psilocybin(experimental)0205.8——
Pilot study of psilocybin in patients with post-treatment lyme disease
2026Secondary
Psilocybin(experimental)14203.2——
Pilot study of psilocybin in patients with post-treatment lyme disease
2026Secondary
Psilocybin(experimental)30203.6——
Pilot study of psilocybin in patients with post-treatment lyme disease
2026Secondary
Psilocybin(experimental)90203.9——
Pilot study of psilocybin in patients with post-treatment lyme disease
2026Secondary
Psilocybin(experimental)180202.7——

Papers Using SF-MPQ

Open Accessindividual

Pilot study of psilocybin in patients with post-treatment lyme disease

In an open‑label, single‑arm pilot study of 20 patients with post‑treatment Lyme disease, two psilocybin sessions with psychological support produced significant, sustained reductions in symptom burden (40% decrease in GSQ‑30 at six months) and improvements in both physical and mental quality of life. The intervention was feasible and well-tolerated with no serious related adverse events, supporting further controlled trials of psilocybin‑assisted therapy for PTLD.

Published
Journal
Scientific Reports
Authors
Garcia-Romeu, A., Naudé, G. P., Rebman, A. W., So, S., Yaffe, A., Geithner, I., Kozero, E. A., Yang, T., Soloski, M. J., Aucott, J. N.
Paywallindividual

Pain mediates the improvement of social functions of repeated intravenous ketamine in patients with unipolar and bipolar depression

This re-analysis of an open-label study (n=103) investigated the effects of ketamine (35mg/70kg, 6x) on pain, depression, and social function in patients with bipolar or unipolar depressive disorder. The results showed that ketamine treatment significantly improved psychosocial functioning and reduced pain index. Mediation analysis revealed that the severity of depressive symptoms and the affective index of pain partially mediated the association between ketamine treatment and improvements in subjective and objective social functioning.

Published
Journal
Journal of Affective Disorders
Authors
Wu, Z., Gan, Y., Li, N., Lan, X., Wang, C., Zhang, F., Liu, H., Li, W., Ye, Y., Hu, Z., Ning, Y., Zhou, Y.

Quick Facts

Full Name
Short Form McGill Pain Questionnaire
Domain
Other
Papers Indexed
2
Score Range
0–45
Interpretation
Lower = better
All Measures